Is stoma always required in patients with Crohn disease undergoing ileocecal resection in the setting of a psoas abscess? A case series

Cover Page

Cite item

Full Text

Abstract

BACKGROUND: In the presence of a penetrating or stricturing–penetrating phenotype of Crohn disease, the formation of a psoas abscess is possible. Ileocecal resection is the most common surgical procedure for complicated Crohn disease. The feasibility of performing an anastomosis in the presence of a psoas abscess remains controversial. The lack of clear management algorithms for Crohn disease with psoas abscess and the rarity of this condition in pediatric patients determine the relevance of the present study.

AIM: To evaluate treatment outcomes and the necessity of stoma formation in patients with complicated Crohn disease undergoing ileocecal resection in the setting of a psoas abscess.

METHODS: The study included data from 8 patients with complicated Crohn’s disease who underwent ileocecal resection in the setting of a psoas abscess. In 6 of 8 patients (75%), no stoma was formed, whereas the remaining patients underwent a two-stage procedure with stoma creation. Intestinal anastomosis was constructed manually using an end-to-end two-layer technique. Broad-spectrum antibacterial therapy was administered preoperatively in 7 of 8 patients (87.5%) for 7–14 days, with a positive clinical and laboratory response.

RESULTS: In half of the patients, the abscess size did not exceed 3 cm, and this group received conservative antibacterial therapy prior to surgery. In 2 patients, the abscess was detected intraoperatively and surgical sanitation was performed. Before ileocecal resection, 7 of 8 patients did not receive glucocorticosteroid therapy; only 1 patient received a minimal dose of prednisolone (5 mg). Partial parenteral nutrition and albumin transfusion for nutritional correction were required in 4 of 8 patients (50%) for 7–14 days. Infectious complications occurred in 4 of 8 patients (50%) and were superficial in nature, not exceeding Grade I on the Clavien–Dindo classification.

CONCLUSION: The presence of a psoas abscess is a potential risk factor for intestinal anastomotic failure but is not a reliable predictor of an unfavorable surgical outcome. When a psoas abscess is identified prior to planned ileocecal resection, conservative treatment or percutaneous drainage is recommended (depending on abscess size), with clinical response assessment over 5–7 days (resolution of fever and reduction in inflammatory laboratory markers). In such cases, we consider primary intestinal anastomosis feasible within 7–14 days.

About the authors

Victoria A. Glushkova

Saint Petersburg State Pediatric Medical University

Author for correspondence.
Email: pedsurgspb@yandex.ru
ORCID iD: 0009-0002-4768-1539
SPIN-code: 8703-3966
Russian Federation, Saint Petersburg

Aleksey V. Podkamenev

Saint Petersburg State Pediatric Medical University

Email: av.podkamenev@gpmu.org
ORCID iD: 0000-0001-6006-9112
SPIN-code: 7052-0205

MD, Dr. Sci. (Medicine), Assistant Professor

Russian Federation, Saint Petersburg

Tatyana V. Gabrusskaya

Saint Petersburg State Pediatric Medical University

Email: tatyanagabrusskaya@yandex.ru
ORCID iD: 0000-0002-7931-2263
SPIN-code: 2853-5956

MD, Cand. Sci. (Medicine), Assistant Professor

Russian Federation, Saint Petersburg

Elena V. Shilova

Saint Petersburg State Pediatric Medical University

Email: komarova_lena@mail.ru
ORCID iD: 0000-0003-2487-0783
Russian Federation, Saint Petersburg

References

  1. Ullrich SJ, Frischer JS. Surgical management of complicated Crohn’s disease. Semin Pediatr Surg. 2024;33(2):151399. doi: 10.1016/j.sempedsurg.2024.151399
  2. Collard MK, Benoist S, Maggiori L, et al. A reappraisal of outcome of elective surgery after successful non-operative management of an intra-abdominal abscess complicating ileocolonic Crohn’s disease: A subgroup analysis of a nationwide prospective cohort. J Crohns Colitis. 2021;15(3):409–418. doi: 10.1093/ecco-jcc/jjaa217
  3. Orscheln ES, Dillman JR, Towbin AJ, et al. Penetrating Crohn disease: does it occur in the absence of stricturing disease? Abdom Radiol. 2018;43(7):1583–1589. doi: 10.1007/s00261-017-1398-7
  4. Lightner AL, Vogel JD, Carmichael JC, et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the surgical management of Crohn’s disease. Dis Colon Rectum. 2020;63(8):1028–1052. doi: 10.1097/DCR.0000000000001716
  5. Kornienko EA, Khavkin AI, Fedulova EN, et al. Draft recommendations of the russian society of pediatric gastroenterology, hepatology and nutrition on diagnosis and treatment of Crohn’s disease in children. Experimental and Clinical Gastroenterology. 2019;(11):100–134. doi: 10.31146/1682-8658-ecg-171-11-100-134 EDN: CFTALD
  6. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification. Inflamm Bowel Dis. 2011;17(6):1314–1321. doi: 10.1002/ibd.21493
  7. Ghoneima AS, Flashman K, Dawe V, et al. High risk of septic complications following surgery for Crohn’s disease in patients with preoperative anaemia, hypoalbuminemia and high CRP. Int J Colorectal Dis. 2019;34(12):2185–2188. doi: 10.1007/s00384-019-03427-7
  8. Versteegh HP, Huijgen D, Meeussen CJHM, et al. A Complicated matter: Predictors for postoperative infections after bowel resection in pediatric inflammatory bowel disease. J Pediatr Surg. 2025;60(3):162105. doi: 10.1016/j.jpedsurg.2024.162105
  9. Gutiérrez A, Rivero M, Martín-Arranz MD, et al. Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN study. Gastroenterol Rep. 2019;7(3):168–175. doi: 10.1093/gastro/goz010
  10. Celentano V, Giglio MC, Pellino G, et al. High complication rate in Crohn’s disease surgery following percutaneous drainage of intra-abdominal abscess: a multicentre study. Int J Colorectal Dis. 2022;37(6):1421–1428. doi: 10.1007/s00384-022-04183-x
  11. Sakurai Kimura CM, Scanavini Neto A, Queiroz NSF, et al. Abdominal surgery in Crohn’s disease: Risk factors for complications. Inflamm Intest Dis. 2021;6(1):18–24. doi: 10.1159/000510999
  12. Kavalukas SL, Scheurlen KM, Galandiuk S. State-of-the-art surgery for Crohn’s disease: Part I—small intestine/ileal disease. Langenbecks Arch Surg. 2022;407(3):885–895. doi: 10.1007/s00423-021-02324-4
  13. Adamina M, Minozzi S, Warusavitarne J, et al. ECCO guidelines on therapeutics in Crohn’s disease: Surgical treatment. J Crohns Colitis. 2024;18(10):1556–1582. doi: 10.1093/ecco-jcc/jjae089
  14. Guo K, Ren J, Li G, et al. Risk factors of surgical site infections in patients with Crohn’s disease complicated with gastrointestinal fistula. Int J Colorectal Dis. 2017;32(5):635–643. doi: 10.1007/s00384-017-2751-6
  15. Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis. 2018;12(1):1–16. doi: 10.1093/ecco-jcc/jjx061
  16. Pfefferkorn MD, Marshalleck FE, Saeed SA, et al. NASPGHAN clinical report on the evaluation and treatment of pediatric patients with internal penetrating Crohn disease: intraabdominal abscess with and without fistula. J Pediatr Gastroenterol Nutr. 2013;57(3):394–400. doi: 10.1097/MPG.0b013e31829ef850
  17. Casas Deza D, Polo Cuadro C, De Francisco R, et al. Initial management of intra-abdominal abscesses and preventive strategies for abscess recurrence in penetrating Crohn’s disease: A national, multicentre study based on ENEIDA registry. J Crohns Colitis. 2024;18(4):578–588. doi: 10.1093/ecco-jcc/jjad184
  18. Feagins LA, Holubar SD, Kane SV, Spechler SJ. Current strategies in the management of intra-abdominal abscesses in Crohn’s disease. Clin Gastroenterol Hepatol. 2011;9(10):842–850. doi: 10.1016/j.cgh.2011.04.023
  19. Dotson JL, Bashaw H, Nwomeh B, Crandall WV. Management of intra-abdominal abscesses in children with Crohn's disease: A 12-year, retrospective single-center review. Inflamm Bowel Dis. 2015;21(5):1109–1114. doi: 10.1097/MIB.0000000000000361
  20. Waked B, Holvoet T, Geldof J, et al. Conservative management of spontaneous intra‐abdominal abscess in Crohn’s disease: Outcome and prognostic factors. J Dig Dis. 2021;22(5):263–270. doi: 10.1111/1751-2980.12984
  21. El-Hussuna A, Karer MLM, Uldall Nielsen NN, et al. Postoperative complications and waiting time for surgical intervention after radiologically guided drainage of intra-abdominal abscess in patients with Crohn’s disease. BJS Open. 2021;5(5):zrab075. doi: 10.1093/bjsopen/zrab075
  22. Bouguen G, Huguet A, Amiot A, et al. Efficacy and safety of tumor necrosis factor antagonists in treatment of internal fistulizing Crohn’s disease. Clin Gastroenterol Hepatol. 2020;18(3):628–636. doi: 10.1016/j.cgh.2019.05.027
  23. Levin A, Risto A, Myrelid P. The changing landscape of surgery for Crohn’s disease. Semin Colon Rectal Surg. 2020;31(2):100740. doi: 10.1016/j.scrs.2020.100740
  24. Neary PM, Aiello AC, Stocchi L, et al. High-risk ileocolic anastomoses for Crohn’s disease: When is diversion indicated? J Crohns Colitis. 2019;13(7):856–863. doi: 10.1093/ecco-jcc/jjz004
  25. Glenisson M, Bonnard A, Berrebi D, et al. Complications and disease recurrence after ileocecal resection in pediatric Crohn’s disease: A Retrospective study. Eur J Pediatr Surg. 2024;34(3):253–260. doi: 10.1055/a-2048-7407
  26. Shcherbakova OV, Shumilov PV. Postoperative complications in children with Crohn’s disease: an analysis of risk predictors. Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2022;12(3):301–310. doi: 10.17816/psaic1284 EDN: QXOVYY
  27. Hashash JG, Elkins J, Lewis JD, Binion DG. AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: Expert review. Gastroenterology. 2024;166(3):521–532. doi: 10.1053/j.gastro.2023.11.303
  28. Sangster W, Berg AS, Choi CS, et al. Outcomes of early ileocolectomy after percutaneous drainage for perforated ileocolic Crohn’s disease. Am J Surg. 2016;212(4):728–734. doi: 10.1016/j.amjsurg.2016.01.044

Supplementary files

Supplementary Files
Action
1. JATS XML

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).